Drugs of Abuse (DOA) Testing Market Size, Insights, Outlook, Overview And Report To 2024-2033

"The new report published by The Business Research Company, titled ""Drugs of Abuse (DOA) Testing Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the drugs of abuse (DOA) testing market size has grown strongly in recent years. It will grow from $6.6 billion in 2023 to $7.25 billion in 2024 at a compound annual growth rate (CAGR) of 9.8%. The drugs of abuse (DOA) testing market size is expected to see strong growth in the next few years. It will grow to $10.48 billion in 2028 at a compound annual growth rate (CAGR) of 9.6%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=9381&type=smp

Surging Global Demand For Drug Abuse Treatment Sparks Growth In Drugs Of Abuse Testing Market
Increasing demand for drug abuse treatment is expected to propel the growth of the drugs of abuse (DOA) testing market going forward. Drug abuse or substance abuse refers to the use of a substance in quantities that are harmful to the user or others. Drug testing aids in the identification of compounds that are not normally found in the body. The process starts with a screening test, which is followed by a second test to find and/or confirm the presence of a substance or substances, so increasing demand for drug abuse treatment will propel the market's growth. For instance, in June 2021, according to the United Nations Office on Drugs and Crime (UNODC), a US-based drug control and crime prevention organization, combining the United Nations International Report 2021 World Drug Report, over 36 million individuals in the world have drug use disorders. Therefore, increasing demand for drug abuse treatment is driving the drug of abuse (DOA) testing market.

Innovative Solutions In The Drugs Of Abuse Testing Market Are Software-As-A-Service (SAAS) Platforms For Enhanced Drug Discovery And Development
Major companies operating in the drugs of abuse (DOA) testing market are focused on developing innovative products such as software-as-a-service platform to strengthen their position in the market. Software-as-a-Service (SaaS) is a software distribution model in which applications are hosted by a third-party provider and made available to customers over the internet. For instance, in December 2023, Merck KGaA, a US-based science and technology company launched Addison drug discovery software. The program expedites drug development and raises the success rate of novel medications and therapies by fusing computer-aided drug design, machine learning, and generative AI. The platform then makes suggestions for the best ways to synthesis these medications, bridging the gap between the design of virtual molecules and their practical manufacturability. The program increases the likelihood that patients will benefit from novel treatments by drawing out hidden insights from large datasets.

The drugs of abuse (DOA) testing market covered in this report is segmented -

1) By Product And Service: Analyzers, Rapid Testing Devices, Consumables, Laboratory Services
2) By Sample Type: Urine, Hair, Oral Fluid, Breath
3) By Application: Pain Management, Criminal Justice, Workplace Screening
4) By End User: Hospitals, Diagnostic Laboratories, Forensic Laboratories, Other End Users

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=9381&type=discount

Major companies operating in the drugs of abuse (DOA) testing market report are Siemens AG, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Inc., Zimmer Biomet Holdings Inc., bioMérieux Inc., Dragerwerk AG & Co. KGaA, Natera Inc., Aegis Sciences Corporation, NMS Labs, Clinical Reference Laboratory Inc., Cordant Health Solutions, Millennium Health, ACM Global Laboratories, Psychemedics Corporation, Alfa Scientific Designs Inc., Alere Toxicology Services, Omega Laboratories Inc., BioTek Laboratories, Premier Biotech Inc., Dominion Diagnostics LLC, Randox Toxicology Ltd., Cansford Laboratories Ltd., United States Drug Testing Laboratories Inc., Homology Medicines Inc., American Bio Medica Corporation, Confirm BioSciences, Immunalysis Corporation, Medtox Diagnostics Inc., Forensic Fluids Laboratories

Contents of the report:
1. Executive Summary
2. Drugs of Abuse (DOA) Testing Market Report Structure
3. Drugs of Abuse (DOA) Testing Market Trends And Strategies
4. Drugs of Abuse (DOA) Testing Market - Macro Economic Scenario
5. Drugs of Abuse (DOA) Testing Market Size And Growth
…..
27. Drugs of Abuse (DOA) Testing Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/drugs-of-abuse-doa-testing-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.